Journavx Market Access Strategy in Focus: What ...

By Rene Pretorius

March 17, 2025

Vertex Pharmaceuticals’ Journavx, a non-opioid pain medication, received
NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access
Tackling the Tuberculosis Burden in Children: A Global Perspective
Rising Chronic Kidney Disease Burden: A Global Health Challenge from 1990 to ...
Cost Savings and Impact of Comprehensive Medication Management in Healthcare
South Africa Launches Patient-Led Cancer Registry
ACS Management Innovations: Transforming Patient Outcomes in Acute Coronary S...
Global Childhood Cancer Access
New Global AIDS Strategy 2030 Aims to End AIDS Threat by 2030
CVD Prevention Models in Sub-Saharan Africa: Insights and Gaps
Strengthening Africa Health Partnership
Pharmacy Benefit Managers Report Reveals Escalating Drug Costs and Calls for ...
HPV Vaccination Males: Addressing High Infection Rates and Preventing Cervica...